Compare Axogen Inc (AXGN) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Eli Lilly And Co — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Eli Lilly And Co trades at $1,212.62 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 413.8× Axogen Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | LLY | |
|---|---|---|
Market Cap | $2.61B | $1.08T |
Sector | Technology | Health |
52-Week High | $48.48 | $1.24K |
52-Week Low | $14.16 | $639.43 |
Enterprise Value | $2.52B | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
